The Food and Drug Administration yesterday approved the first FDA-approved vaccine to prevent Ebola in adults with Zaire ebolavirus, which killed more than 10,000 people during a 2014-2016 outbreak in West Africa. Studies of the vaccine conducted in West Africa, and individuals in Canada, Spain and the U.S. supported its approval. “While the risk of Ebola virus disease in the U.S. remains low, the U.S. government remains deeply committed to fighting devastating Ebola outbreaks in Africa, including the current outbreak in the Democratic Republic of the Congo,” said Anna Abram, FDA deputy commissioner for policy, legislation and international affairs. The Centers for Disease Control and Prevention this week updated its guidance on using rapid diagnostic tests for Ebola in the U.S.

Related News Articles

Headline
The Centers for Disease Control and Prevention yesterday joined the World Health Organization to declare the end of the Ebola Virus Disease outbreak in the…
Headline
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living…
Headline
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which…
Headline
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those…